Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Ophthalmology
Published in: International Ophthalmology 3/2020

01-03-2020 | Glaucoma | Original Paper

Medium-term clinical outcomes following Xen45 device implantation

Authors: Aitor Fernández-García, Ying Zhou, Mercedes García-Alonso, Henry D. Andrango, Francisco Poyales, Nuria Garzón

Published in: International Ophthalmology | Issue 3/2020

Login to get access

Abstract

Purpose

To evaluate medium-term clinical outcomes with microstent XEN® 45 Gel Stent (Allergan Dublin, Ireland) for treatment of primary open-angle glaucoma (POAG).

Material and methods

This is a retrospective, descriptive and observational study involving 93 eyes from 63 patients who had undergone POAG surgery with a XEN® 45 Gel Stent implantation and had been followed up and controlled between 12 and 36 months.

Results

IOP dropped from 18.23 ± 5.00 mmHg pre-op to 14.16 ± 2.14, 14.47 ± 2.16 and 14.63 ± 1.91 at 1, 2 and 3 years after surgery (p = 0.000, 0.000 and 0.001) consecutively. Mean number of medications dropped from 1.87 ± 0.94 preoperatively to 0.31 ± 0.69, 0.34 ± 0.63 and 1.00 ± 0.88 (p = 0.000, 0.000 and 0.017) at 12, 24 and 36 months. Mean visual field deviation values never turned out to be significant for any of the follow-up visit data. A total of 94.6% of the surgical procedures turned out to be complication-free. In one surgery, the procedure failed and 18 months later other device was implanted.

Conclusion

POAG surgical procedures with XEN® 45 Gel Stent implants are a safe and effective treatment approach.
Literature
1.
Saheb H, Ahmed II (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23(2):96–104CrossRef
2.
Agrawal P, Bradshaw SE (2018) Systematic literature review of clinical and economic outcomes of micro-invasive glaucoma surgery (MIGS) in primary open-angle glaucoma. Ophthalmol Ther 7(1):49–73CrossRef
3.
4.
Vinod K, Gedde SJ (2017) Clinical investigation of new glaucoma procedures. Curr Opin Ophthalmol 28(2):187–193CrossRef
5.
Smith M et al (2019) 1-year outcomes of the Xen45 glaucoma implant. Eye (Lond) 33(5):761–766CrossRef
6.
Sheybani A et al (2015) Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: pilot study. J Cataract Refract Surg 41(9):1905–1909CrossRef
7.
Lewis RA (2014) Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg 40(8):1301–1306CrossRef
8.
Loewen NA, Schuman JS (2013) There has to be a better way: evolution of internal filtration glaucoma surgeries. Br J Ophthalmol 97(10):1228–1229CrossRef
9.
Mansouri K et al (2018) Prospective evaluation of XEN Gel implant in eyes with pseudoexfoliative glaucoma. J Glaucoma 27(10):869–873CrossRef
10.
De Gregorio A et al (2018) Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 38(3):1129–1134CrossRef
11.
Lenzhofer M et al (2019) Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clin Exp Ophthalmol 47(5):581–587CrossRef
12.
Karimi A et al (2018) Efficacy and safety of the ab-interno Xen gel stent after failed trabeculectomy. J Glaucoma 27(10):864–868CrossRef
13.
Fernandez-Garcia A, Romero C, Garzon N (2015) "Dry Lake" technique for the treatment of hypertrophic bleb following Xen® Gel Stent placement. Arch Soc Esp Oftalmol 90(11):536–538CrossRef
Metadata
Title
Medium-term clinical outcomes following Xen45 device implantation
Authors
Aitor Fernández-García
Ying Zhou
Mercedes García-Alonso
Henry D. Andrango
Francisco Poyales
Nuria Garzón
Publication date
01-03-2020
Publisher
Springer Netherlands
Keyword
Glaucoma
Published in
International Ophthalmology / Issue 3/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-019-01232-3

Other articles of this Issue 3/2020

International Ophthalmology 3/2020 Go to the issue

Original Paper

Postoperative eccentric macular holes after surgery for vitreomacular interface diseases

Original Paper

Atypical herpes simplex keratitis: frequency, clinical presentations and treatment results

Original Paper

Toric IOL positioning with a no-touch head-up display axis alignment

Original Paper

Analysis of different types of anesthesia in descemet membrane endothelial keratoplasty

Original Paper

Effects of vitamin D deficiency on intraocular pressure values obtained by ocular response analyzer

Original Paper

Predictors for recovery of macular function after surgery for primary macula-off rhegmatogenous retinal detachment